Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

47 results found for Haematology in London, UK

Sort by:
Showing 1 - 10 of 47 results
Haematology
20 years of experience
Haematological Malignancy

Dr Kate Stringaris is a Consultant Haematologist and Clinical Scientist with many years clinical  experience in the treatment of blood disorders and immune system deficiencies using cellular therapies  and stem cell transplantation.

Dr Stringaris earned her primary medical qualification at University College London. She completed her basic training at St George’s Hospital and undertook her specialist haematology training at the Royal Free Hospital and Hammersmith Hospital. Finding her passion for haematology, she went on to complete a PhD in Leukaemia at Imperial College London and was appointed Senior Clinical Lecturer, attending as consultant haematologist at St Bart’s Hospital London. 

Dr Stringaris travelled to the USA to continue her studies, investigating immune defects and transplantation immunology as a senior research physician at the National Heart Lung and Blood Institute, National Institutes of Health. Her work focused on stem cell therapies, natural killer cell immunity and novel immune therapies for acute myeloid leukaemia.

Special interests

Dr Kate Stringaris specialises in  the following areas: 

• Natural killer cell immunity

• Novel immune therapies for acute myeloid leukaemia

• Stem cell therapies

Read more
Haematology
Recommended by 1 specialist
33 years of experience

Dr Panos Kottaridis is a Consultant Haematologist in Leukaemia and Bone Marrow Transplantation at University College London Hospitals NHS.

His main academic and clinical interests focus on prognostication of acute myeloid leukaemia (AML), bone marrow transplantation, late effects of chemotherapy/ bone marrow transplantation, fertility in recipients of chemotherapy and immunotherapy of haematological malignancies (i.e. monoclonal antibodies, CAR-T cells).

Dr Kottaridis is a member of the National Cancer Research Network (Former MRC) working party for AML. He has published more than 74 papers in peer-reviewed journals and more than 4000 scientific papers have cited his work; he has also contributed with two chapters in Haematology textbooks.

Dr Kottaridis is an enthusiastic teacher and lecturer having given more than 200 lectures and presentations in national and international meetings.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.


Diseases, Medical Tests and Treatments
  • Bone Marrow Transplantation
  • Immunotherapy
  • Acute Myeloid Leukaemia (AML)
  • Bone Marrow Transplantation
  • Treating Haematological Malignancies with Immunotherapy
  • Late Effects of Chemotherapy/ Bone Marrow Transplantation
  • Fertility in Recipients of Chemotherapy 
Read more
Haematology
28 years of experience

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more
Haematology
33 years of experience

Dr Charalampia Kyriakou is a Consultant Haematologist at University College London Hospitals NHS Trust (UCLH), London North West University Healthcare NHS Trust (LNWH) and the Royal National Orthopaedic Hospital Myeloma Spinal Service. She also prides a first-class service with HCA Healthcare, where she helps patients suffering from multiple myeloma, lymphoma and other blood cancers. She also specialises in stem cell transplantation for multiple, lymphoma and for patients with multiple sclerosis.

She offers a holistic approach to treatments, with her patients best interest at heart at all times. She is dedicated to improving outcomes and wellbeing for her patients.

After qualifying with a Medical Degree, she completed an extensive rotational training scheme in haematology at University College London Hospital before being appointed as Consultant. Since then she has been appointed to numerous committees and teams, including the stem cell transplantation team for Myeloma at UCLH, the Myeloma Spinal Service at RNOH and is the Lead for Myeloma and Lymphoma services at LNWH.

She is heavily involved in national and international clinical trials with a passion for improving cancer outcomes. During her career, she has published over 50 peer-reviewed papers and contributed to two chapters in haematology textbooks.


Diseases, Medical Tests and Treatments
  • Chemotherapy for haematological blood cancer conditions
  • Stem Cell Transplantation for Myeloma, Lymphoma and Multiple Sclerosis
  • Multiple Myeloma paraproteinemias
  • Lymphoma (Non-Hodgkin's and Hodgkin's Lymphoma)
  • Transplation for Myeloma and Lymphoma
Read more
Haematology
37 years of experience

Professor Kwee Lan Yong is a specialist in Haematological Oncology and one of the leading specialists in the treatment of patients with multiple myeloma.

She completed her medical training at Oxford University and University College London (UCL), before undertaking doctoral studies at UCL and was awarded a PhD in 1993 for her research into growth factors. In 1999 she was appointed as a Senior Lecturer and Honorary Consultant at UCL, before becoming Clinical and Academic Lead in Multiple Myeloma at University College Hospital and the North London Cancer Network (NLCN).


Dr Yong runs an active trials programme and a laboratory research programme. She has published more than 60 original papers in peer-reviewed journals, and is a reviewer for international journals and grant-awarding bodies. She runs the undergraduate course for Haematology at UCL Medical School and regularly speaks at international conferences.


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Haematological Stem Cell Transplantation

Myeloma 

Read more
Haematology
24 years of experience

Dr Rakesh Popat is a Consultant Haematologist with specialist expertise in Multiple Myeloma. His NHS base is at University College Hospital, London where he leads the Myeloma Clinical Trials Program and is the Cancer Program lead for the NIHR UCLH Clinical Research Facility. He has particular experience with novel treatments including immunotherapies such as CAR-T cell therapy and new antibody approaches.

Dr Popat is the Chair of the UK Myeloma Research Alliance and is on the leadership boards of the UK Myeloma Forum and the European Myeloma Network. In addition, he is the Haematology lead for the North Thames Clinical Research Network. He completed a PhD in novel treatments for Myeloma and was awarded a Fellowship to attend the Dana Farber Cancer Institute, Boston USA as part of this.

Diseases, Medical Tests and Treatments

Multiple Myeloma: diagnosis, treatment, stem cell transplant and a specific interest in new treatments including immunotherapies

Read more
Haematology
25 years of experience

Dr Neil Rabin is a Consultant Haematologist who works at University College Hospital. His special interests include clinical trials evaluating new treatments for myeloma at diagnosis and at relapse.


Diseases, Medical Tests and Treatments
  • Clinical trials evaluating new treatments for myeloma at diagnosis and at relapse
Read more
Haematology
44 years of experience

Dr Robert Marcus, MA, FRCP, FRCPath is a Consultant Haematologist working at LOC Harley St and Chelsea, and London Bridge Hospital.

He qualified in Medicine from University College Hospital Medical School in London in 1977 and specialised in haematology at the Royal Postgraduate Medical School and the Royal Free Hospital.He was appointed Consultant Haematologist in Addenbrooke’s Hospital in Cambridge in 1987 where he established the regional bone marrow transplant unit and developed particular expertise in lymphoma and other haematological malignancies. He moved to Kings College Hospital in 2008 where he remained as Consultant Haematologist until 2017 when he left the NHS after 40 years service, 30 at Consultant level, to work solely in the private sector

Dr Marcus’ research interests include the development of novel therapies for lymphoma, where he has been Chief investigator in a large number of practice-changing studies. More recently he developed further expertise in the management of Cerebral Lymphoma and Lymphoproliferative disorders in patients with HIV and after organ transplantation.

Dr Marcus was chairman of the NCRI low-grade lymphoma working for the party and has been an examiner for the Royal College of Pathologists. He is a medical advisor to ' Lymphoma Action' and Vice President of 'Leukaemia Care'.

Dr Marcus has authored more than 150 peer-reviewed manuscripts and reviews, including national guidelines on follicular, cerebral and post-transplant lymphoma. He has co-edited or contributed to 4 books, including the most recent edition of Post Graduate Haematology and textbooks on Multiple Myeloma and Lymphoma


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Haemato-Oncology:

Lymphoma , Hodgkins Disease

Lymphoproliferative disorders

Myeloma 

General Haematology

Iron Deficiency 

Iron overload /Haemochromatosis 



Read more
Haematology
38 years of experience

Professor John Pasi Consultant Haematologist specialising in haemostasis and thrombosis, with a particular clinical interest in thrombosis due to an inherited condition or resulting from age-related and chronic disease-related changes during later life. He also treats patients with a variety of bleeding problems including genetic conditions such as von Willebrand disease and haemophilia.

Professor Pasi graduated in medicine from the University of Birmingham in 1983 completing specialist training in haematology at Birmingham Children’s Hospital. He was awarded a PhD for his research and in 1993 was appointed as Consultant Haematologist and Honorary Senior Lecturer at the Royal Free Hospital and School of Medicine, where he remained until 1999. He was then appointed Professor of Haematology at the University of Leicester, as well as Head of Haematology Services at the University Hospitals of Leicester NHS Trust.

Outside his clinical work, he is keen to promote good practice in haematology, helping to develop various national guidelines concerned with how haemostatic and thrombotic disorders should be optimally treated.


Diseases, Medical Tests and Treatments

Treatment of:

  • Blood coagulation
  • Thrombosi
  • Bleeding disorders
  • Venous thromboembolism (DVT and PE)
  • Anticoagulation
  • Haemostasis
  • Thrombosis
  • Inherited clotting disorders
  • Von Willebrand disease
  • Haemophilia
  • Pulmonary thrombo-embolism
  • Bleeding disorders
Read more
Haematology
20 years of experience
Haematological Malignancy

Dr Ali Rismani, Consultant Haematologist is currently situated in London working within the Whittington Health NHS Trust as well as providing private care within the University College Hospital. He is highly specialised in the diagnosis and management of all blood cancers with a specific interest in myeloma, lymphoma and chronic lymphocytic leukaemia (CLL), and is highly experienced in all aspects of general haematology.

Dr Rismani begun his medical education at Imperial College Medical School where he graduated in Medicine in 2001. He then went on to complete his Higher Specialist Training in Haematology in London and Cambridge.

Dr Rismani is a respected educator holding the post of Honorary Clinical Lecturer at University College London (UCL). He is also an active member of the research community focusing on Waldenstrom Macroglobulinemia (AKA Lymphoplasmacytic Lymphoma). He has been involved in several high-profile clinical trials for this rare non-Hodgkin B cell lymphoma, resulting in numerous peer-reviewed publications. 

Read more